-
1Academic Journal
المؤلفون: M. S. Vonsky, A. L. Runov, T. S. Gorjachaya, A. M. Koltsova, E. V. Kurchakova, V. D. Nazarov, S. V. Lapin, A. V. Mazing, V. L. Emanuel, М. С. Вонский, А. Л. Рунов, Т. С. Горячая, А. М. Кольцова, Е. В. Курчакова, В. Д. Назаров, С. В. Лапин, А. В. Мазинг, В. Л. Эмануэль
المساهمون: Cell cultures were provided by the CUC «Vertebrate Cell Culture Collection». The research was supported by the Ministry of Education and Science of the Russian Federation, Agreement № 075‑15‑2021‑683., Клеточные культуры предоставлены ЦКП «Коллекция культур клеток позвоночных». Работа выполнена при финансовой поддержке гранта Минобрнауки Российской Федерации, Соглашение № 075‑15‑2021‑683.
المصدر: Measurement Standards. Reference Materials; Том 19, № 2 (2023); 5-17 ; Эталоны. Стандартные образцы; Том 19, № 2 (2023); 5-17 ; 2687-0886
مصطلحات موضوعية: число копий последовательности, cancer diagnostics, laboratory medicine, nucleotide sequence, sequence copy number, онкодиагностика, лабораторная медицина, последовательность нуклеотидов
وصف الملف: application/pdf
Relation: https://www.rmjournal.ru/jour/article/view/384/279; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries / H. Sung [et al.] // CA: A Cancer Journal for Clinicians. 2021. Vol. 71, № 3. P. 209–249. https://doi.org/10.3322/caac.21660; Loeb K. R., Loeb L. A. Significance of multiple mutations in cancer // Carcinogenesis. 2000. Vol. 21, № 3. P. 379–385. https://doi.org/10.1093/carcin/21.3.379; Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers / K. B. Kuchenbaecker [et al.] // JAMA. 2017. Vol. 317, № 23. P. 2402–2416. https://doi:10.1001/jama.2017.7112; Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies / A. Antoniou [et al.] // American Journal of Human Genetics. 2003. Vol. 72, № 5. P. 1117–1130. https://doi:10.1086/375033; Chen S., Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance // Journal of Clinical Oncology. 2007. Vol. 25, № 11. P. 1329–1333. https://doi:10.1200/JCO.2006.09.1066; Cancer risks associated with BRCA1 and BRCA2 pathogenic variants / S. Li [et al.] // Journal of Clinical Oncology. 2022. Vol. 40, № 14. P. 1529–1541. https://doi.org/10.1200/JCO.21.02112; Berger M. F., Mardis E. R. The emerging clinical relevance of genomics in cancer medicine // Nature Reviews Clinical Oncology. 2018. Vol. 15, № 6. P. 353–365. https://doi.org/10.1038/s41571-018-0002-6; Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment / K. Haratani [et al.] // Annals of Oncology. 2017. Vol. 28, № 7. P. 1532–1539. https://doi.org/10.1093/annonc/mdx183; Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer / E. V. Cutsem [et al.] // Journal of Clinical Oncology. 2015. Vol. 33, № 7. P. 692–700. https://doi.org/10.1200/JCO.2014.59.4812; Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements / Hua-Jun He [et al.] // Biomolecular Detection and Quantification. 2016. Vol. 8. P. 1–8. https://doi.org/10.1016/j.bdq.2016.02.001; Development and interlaboratory evaluation of a NIST reference material RM 8366 for EGFR and MET gene copy number measurements / H. J. He [et al.] // Clinical Chemistry and Laboratory Medicine. 2019. Vol. 57, № 8. P. 1142–1152. https://doi.org/10.1515/cclm-2018–1306; Metrological framework to support accurate, reliable, and reproducible nucleic acid measurements / M. Milavec [et al.] // Analytical and Bioanalytical Chemistry. 2022. Vol. 414, № 2. P. 791–806. https://doi.org/10.1007/s00216–021–03712-x; Alkabban F. M., Ferguson T. Breast cancer. Treasure Island: StatPearls Publishing, 2022. URL: https://www.ncbi.nlm.nih.gov/books/NBK482286 (дата обращения: 08.11.2022).; Activating HER2 mutations in HER2 gene amplification negative breast cancer / R. Bose [et al.] // Cancer Discov. 2013. Vol. 3, № 2. P. 224–237. https://doi.org/10.1158/2159–8290.CD-12–0349; Iqbal N., Iqbal N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications // Molecular Biology International. 2014. № 852748. https://doi:10.1155/2014/852748; Moasser M. M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis // Oncogene. 2007. Vol. 26, № 45. P. 6469–6487. https://doi:10.1038/sj.onc.1210477; Centromere 17 copy number gain reflects chromosomal instability in breast cancer / K. Lee [et al.] // Scientific Reports. 2019. Vol. 9, № 1. P. 17968. https://doi.org/10.1038/s41598–019–54471-w; Scherer W. F., Syverton J. T., Gey, G. O. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix // Journal of Experimental Medicine. 1953. Vol. 97, № 5. P. 695–710. https://doi:10.1084/jem.97.5.695; Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples / Y. Zhu [et al.] // Experimental and Molecular Pathology. 2015. Vol. 100, № 2. P. 287–293. https://doi:10.1016/j.yexmp.2015.11.027; Certification of standard reference material 2372a; Human DNA quantitation standard / E. L. Romsos [et al.] // NIST Special Publication. 2018. P. 260–189. https://doi:10.6028/NIST.SP.260–189; Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases / L. Stuppia [et al.] // International Journal of Molecular Sciences. 2012. Vol. 13, № 3. P. 3245–3276. https://doi:10.3390/ijms13033245; Cousineau I., Belmaaza A. EMSY overexpression disrupts the BRCA2/ RAD51 pathway in the DNA-damage response: Implications for chromosomal instability/recombination syndromes as checkpoint diseases // Molecular Genetics and Genomics. 2011. Vol. 285, № 4. P. 325–340. https://doi:10.1007/s00438-011-0612-5; https://www.rmjournal.ru/jour/article/view/384
-
2
المؤلفون: Fan Jiajia, Min Chen, Peng Jiang, Jun-jie Bai, Qing Jian, Shiling Xia, Xing Ye
المصدر: African Journal of Biotechnology; Vol 11, No 30 (2012); 7756-7765
مصطلحات موضوعية: Genetics, biology, Transgene, fungi, Tanichthys, biology.organism_classification, Applied Microbiology and Biotechnology, Genome, Molecular biology, Homology (biology), Transgenic fish, Tanichthys albonubes, RFP, expression, flanking sequence, copy number, P1 phage, GenBank, Agronomy and Crop Science, Molecular Biology, Gene, Zebrafish, Biotechnology
وصف الملف: application/pdf